Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Eir
  6. /
  7. Greenfield Global USA Inc
EIR
•Greenfield Global USA Inc•May 21, 2015

Greenfield Global USA Inc – FDA EIR, May 21, 2015

Record Details

A pre-approval inspection was conducted by the FDA at Pharmco Products, Inc. DBA Pharmco-AAPER in Brookfield, CT, from May 19 to May 21, 2015. The inspection, carried out under CPGM 7346.832 for pre-approval inspections covering New Drug Applications (NDA) and USP standards, focused on the firm as a repacker of Active Pharmaceutical Ingredients (APIs) and industrial chemicals. The inspection revealed four significant objectionable conditions, resulting in the issuance of an FDA-483. Key issues included the company's failure to establish appropriate specifications for APIs, particularly regarding endotoxin and bioburden, suitable for products intended for use in sterile injectable drugs. Furthermore, the firm failed to implement adequate controls to prevent the distribution of products for uses beyond their stated intention, specifically after being informed that their USP-grade ethyl alcohol would be used as an API. Manufacturing deficiencies were also noted, such as the absence of filter integrity or bacterial retention tests for the final filtration step, and the filling of API in an unclassified manufacturing environment lacking suitable design to limit microbiological contaminants. Lastly, the company had not validated its cleaning operations to ensure equipment cleanliness for its intended use. In response to these findings, Pharmco-AAPER management indicated their consideration to withdraw their name from the New Drug Application, rather than implementing the extensive additional controls required to address the observations.

Company
Greenfield Global USA Inc
Inspection date
May 21, 2015
Product type
drugs
Office
New England District Office
People
  • Paul A. DiMarco (recipient)
  • Elena Frenkel (company_representative)
  • Maya M. Davis (Assuring that quality medicines are available to the American public)
View Company Profile

ID · 5a1b458b-c66a-4a1f-a36b-b2e6656c5976

Other documents for Greenfield Global USA Inc
  • 483 - 2022-01-18January 18, 2022

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Greenfield Global USA Inc
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.